According to a recently published report, the global Market And Manufacturing Technologies For Protein Drugs is expected to grow at the CAGR 16% during 2015-2022. The segmentation of global markets and manufacturing technologies for protein drugs is based on types, technology, product, end-users and geography. The report on global market and manufacturing technologies for protein drugs forecast 2015-2022 (types, technology, product, end-users and geography) provides detailed overview and predictive analysis of the market.
Detailed study on this Report : http://www.briskinsights.com/report/market-and-manufacturing-technologies-for-protein-drugs-market
The growth and demand of the global markets and manufacturing technologies for protein drugs is experiencing a healthy growth in the developed and developing countries. In 2015 the protein drug market generated more than $705.5 million and is expected to generate more than $1500 million by 2022. The major drivers that accelerates the market are increasing consumption of protein drugs, increase in the number of life style diseases, increasing capital for R&D of protein drugs technology. The major drivers accelerates the market and increases the demand of protein drugs in developed and developing countries. It has been observed that in 2015 more than 23% of death was caused because of unhealthy food and malnutrition, worldwide. According to world health organization, out of total death population more than 5.9 million children under age 5 died; 16,000 every day, globally. The increase in the number of deaths due to malnutrition has in turn increased the market of overall pharmaceutical companies, eventually increasing the market of protein drugs. The extortionate and high maintenance tools and instruments used in protein drug technology and high regulation and involvement of government in pharmaceutical sector become the major restraints that has hindered the market of protein drug technology market globally. The increasing cost for R&D activities and development of new products become the major challenge for the protein drug technology companies.
For Same Category Reports Visit Here: http://www.briskinsights.com/category/manufacturing-industry
Scope of the report
1. Global Markets and Manufacturing Technologies for Protein Drugs by Types 2012-2022 ($ billion)
1.1. Recombinant human proteins drugs
1.2. Monoclonal antibodies
1.5. Bactel Priarotein Drugs
2. Global Markets and Manufacturing Technologies for Protein Drugs by Technology 2012-2022 ($ billion)
2.1. Rational protein design
2.2. Irrational protein design
3. Global Markets and Manufacturing Technologies for Protein Drugs by Product 2012-2022 ($ billion)
3.3. Services and software
4. Global Markets and Manufacturing Technologies for Protein Drugs by End-Users 2012-2022 ($ billion)
4.1. Academic research institutes
4.2. Contract research organization
4.3. Pharmaceutical and Biotechnology companies
5. Pediatric Medicines Market Regional Outlook 2012-2022 ($ billion)
5.1. North America
5.3. Asia Pacific
5.4. Middle East & Africa
5.5. Central & South America
6. Company Profiles
6.1. Agilent Technologies, Inc.
6.2. Bio-Rad Laboratories, Inc
6.4. Borean Pharma
6.5. Bruker Corporation
6.6. Compound Therapeutics
6.7. Danaher Corporation
6.10. Genscripts USA, Inc.
6.11. Johnson & Johnson
6.12. Perkinelmer, Inc.
6.13. Pieris ProteoLab
6.14. Sigma-Aldrich Corporation
6.15. Thermo Fisher Scientific
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Contact Us :
109 Vernon House
Phone : +448081890034 (UK)
Email : email@example.com
Website : http://www.briskinsights.com/